This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $450,330
Synthetic biology approaches to design living medicines to improve intestinal and metabolic health.
CIHR · 2019 · Principal investigator
Synthetic biology approaches to design living medicines to improve intestinal and metabolic health.
Principal investigators: Philpott, Dana J; Tompkins, Thomas A; Mahadevan, Radhakrishnan
Keywords: Crohn'S Disease; Intestinal Inflammation; Metabolic Syndrome; Mouse Models; Probiotics; Synthetic Biology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.